title: Risk-benefit analysis of nucleic acid testing: the French experience.
authors.affiliation: Agence Française du Sang, France.
authors.forename: C
authors.initials: C
authors.lastname: Saura
authors.forename: A M
authors.initials: AM
authors.lastname: Couroucé
authors.forename: J
authors.initials: J
authors.lastname: Pillonel
authors.forename: D
authors.initials: D
authors.lastname: Costagliola
authors.forename: B
authors.initials: B
authors.lastname: Flan
authors.forename: C
authors.initials: C
authors.lastname: Defer
authors.forename: J
authors.initials: J
authors.lastname: Coste
authors.forename: C
authors.initials: C
authors.lastname: Rouzioux
mesh_terms: D001782:Blood Donors; D001803:Blood Transfusion; D003362:Cost-Benefit Analysis; D005602:France; D006678:HIV / Q000302:isolation & purification; D016174:Hepacivirus / Q000302:isolation & purification*; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D010949:Plasma / Q000821:virology; D012367:RNA, Viral / Q000097:blood*; D012307:Risk Factors; D065227:Transfusion Reaction
chemical_list: D012367:RNA, Viral